We offer flexible partnership models from co-development to licensing, tailored to your asset strategy and business objectives. If you are interested in turning your molecule into a long-acting injectable, or extending the lifecycle of your current injectable, let’s talk about how we can help, contact us at bd@nanomi.com.
Creating value where patient needs, partner goals, and our expertise meet
Great partnerships create value for everyone. Patients want the best treatment outcomes with fewer injections and a lighter treatment burden. Partners want differentiation, lifecycle extension, and efficient development pathways. Nanomi brings these together through our long-acting injectable platforms, development expertise, formulation know-how, and a collaborative partnership approach.
Our platforms: built to improve patient outcomes and address partner needs
Our proprietary technology platforms work with a range of complex molecules to help companies extend the lifecycle of products, whether in development or already on the market, by transforming them into longer-acting formulations. This supports improved patient outcomes and convenience, while unlocking new market opportunities for established therapies.
Why partners choose Nanomi’s platforms
- Can be used with a range of complex molecules (including small molecules, peptides, and biologics to be formulated into nanoparticles or microspheres)
- Consistent, controlled-release medicines supporting treatment durations from weeks to months
- Uniform particle size, shape, and biological properties, enabling predictable and reliable drug performance
- Potential for improved injectability, as controlled particle sizes may enable smaller needles and help reduce injection burden
- De-risked through regulatory experience, with commercial readiness of the platform and FDA approval of the lead product
Proven expertise and scalable solutions
Coupled with regulatory expertise and established, scalable manufacturing processes, Nanomi supports a seamless path to help partners move from concept to commercialization. We provide:
- Custom pharmaceutical manufacturing services
- Pharmaceutical research and development, including development of medicines and preparations, laboratory research services, and drug development and product innovation
- Pharmaceutical R&D consulting, to accelerate feasibility decisions, develop complex injectable programs, scale up to commercial, and shape overall development strategies
- Pharmaceutical compounding services for personalized treatment solutions
We offer flexible partnership models from co-development to licensing, tailored to your asset strategy and business objectives. If you are interested in turning your molecule into a long-acting injectable, or extending the lifecycle of your current injectable, let’s talk about how we can help, contact us at bd@nanomi.com.
News and
Events
CRS Lisbon
Exchange program
